We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

ENDRA Life Sciences Inc (NDRA) USD0.0001

Sell:$0.47 Buy:$0.47 Change: $0.24 (29.29%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$0.47
Buy:$0.47
Change: $0.24 (29.29%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$0.47
Buy:$0.47
Change: $0.24 (29.29%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ENDRA Life Sciences Inc. develops technology for increasing the capabilities of clinical diagnostic ultrasound to broaden patient access to the diagnosis and treatment of various medical conditions in circumstances where other diagnostic technologies are unavailable or impractical. The Company has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and staging the progression of non-alcoholic fatty liver disease (NAFLD), which, if untreated, can progress to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The Company's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Contact details

Address:
3600 Green Ct Ste 350
ANN ARBOR
48105-2440
United States
Telephone:
+1 (734) 3350468
Website:
https://www.endrainc.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NDRA
ISIN:
US29273B3024
Market cap:
$6.94 million
Shares in issue:
8.45 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Francois Michelon
    Chairman of the Board, Chief Executive Officer
  • Irina Pestrikova
    Senior Director of Finance
  • Michael Thornton
    Chief Technology Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.